On October 23, 2009
Amgen’s Denosumab Turned Down Again, but It May Not Be as Bad as It Seems
When it rains at Amgen, it pours. Days after the FDA rejected two of six approval applications for bone loss drug denosumab, it nixed the rest as well.
0 Comments